These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4226271)

  • 1. A plasmin-split fragment of C'3 as a new chemotactic factor.
    Ward PA
    J Exp Med; 1967 Aug; 126(2):189-206. PubMed ID: 4226271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures.
    Taylor FB; Ward PA
    J Exp Med; 1967 Jul; 126(1):149-58. PubMed ID: 4226164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    NILSSON UR; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):277-98. PubMed ID: 14316946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.
    Gewurz H; Shin HS; Mergenhagen SE
    J Exp Med; 1968 Nov; 128(5):1049-57. PubMed ID: 4176223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of the fifth component of complement in mice with an inherited complement defect.
    Nilsson UR; Müller-Eberhard HJ
    J Exp Med; 1967 Jan; 125(1):1-16. PubMed ID: 4959665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modification of complement factors and their inhibitors during meningococcal sepsis (author's transl)].
    Blanco A; Solís P; Alvarez Guisasola FJ; Valbuena C; Gómez C; Prieto P; Ruíz C
    An Esp Pediatr; 1980 Aug; 13(8):679-88. PubMed ID: 7436149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
    Snyderman R; Gewurz H; Mergenhagen SE
    J Exp Med; 1968 Aug; 128(2):259-75. PubMed ID: 4873021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited deficiency of the third component of human complement (C'3).
    Alper CA; Propp RP; Klemperer MR; Rosen FS
    J Clin Invest; 1969 Mar; 48(3):553-7. PubMed ID: 5773091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    Müller-Eberhard HJ; Polley MJ; Calcott MA
    J Exp Med; 1967 Feb; 125(2):359-80. PubMed ID: 6019133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inactivation of complement and its components by plasmin.
    PILLEMER L; RATNOFF OD; BLUM L; LEPOW IH
    J Exp Med; 1953 Apr; 97(4):573-89. PubMed ID: 13052820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.
    Müllerèberhard HJ; Dalmasso AP; Calcott MA
    J Exp Med; 1966 Jan; 123(1):33-54. PubMed ID: 4159289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Irregular behavior of complement in coeliac disease (author's transl)].
    Blanco A; Alonso M; Solís P; Calvo C; Catoira A; Sánchez Villares E
    An Esp Pediatr; 1981 Nov; 15(5):449-54. PubMed ID: 7332146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of the sixth component of complement in rabbits with an inherited complement defect.
    Rother K; Rother U; Müller-Eberhard HJ; Nilsson JR
    J Exp Med; 1966 Oct; 124(4):773-85. PubMed ID: 5922290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neutrophil chemotactic factor from human C'5.
    Ward PA; Newman LJ
    J Immunol; 1969 Jan; 102(1):93-9. PubMed ID: 5765461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.